Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells
- PMID: 17658950
- PMCID: PMC1924871
- DOI: 10.1371/journal.ppat.0030110
Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells
Abstract
The survival and persistence of Mycobacterium tuberculosis depends on its capacity to manipulate multiple host defense pathways, including the ability to actively inhibit the death by apoptosis of infected host cells. The genetic basis for this anti-apoptotic activity and its implication for mycobacterial virulence have not been demonstrated or elucidated. Using a novel gain-of-function genetic screen, we demonstrated that inhibition of infection-induced apoptosis of macrophages is controlled by multiple genetic loci in M. tuberculosis. Characterization of one of these loci in detail revealed that the anti-apoptosis activity was attributable to the type I NADH-dehydrogenase of M. tuberculosis, and was mainly due to the subunit of this multicomponent complex encoded by the nuoG gene. Expression of M. tuberculosis nuoG in nonpathogenic mycobacteria endowed them with the ability to inhibit apoptosis of infected human or mouse macrophages, and increased their virulence in a SCID mouse model. Conversely, deletion of nuoG in M. tuberculosis ablated its ability to inhibit macrophage apoptosis and significantly reduced its virulence in mice. These results identify a key component of the genetic basis for an important virulence trait of M. tuberculosis and support a direct causal relationship between virulence of pathogenic mycobacteria and their ability to inhibit macrophage apoptosis.
Conflict of interest statement
Figures
References
-
- Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA. 2005;293:2767–2775. - PubMed
-
- Manabe YC, Bishai WR. Latent Mycobacterium tuberculosis—Persistence, patience, and winning by waiting. Nat Med. 2000;6:1327–1329. - PubMed
-
- Honer zu Bentrup K, Russell DG. Mycobacterial persistence: Adaptation to a changing environment. Trends Microbiol. 2001;9:597–605. - PubMed
-
- Hingley-Wilson SM, Sambandamurthy VK, Jacobs WR., Jr Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis . Nat Immunol. 2003;4:949–955. - PubMed
-
- Smith CV, Sharma V, Sacchettini JC. TB drug discovery: Addressing issues of persistence and resistance. Tuberculosis (Edinb) 2004;84:45–55. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
